Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma

Fig. 1

HNSCC patients with low CBR1 expression show a good prognosis for radiation therapy. a, Immunohistochemical analysis. Typical staining intensities from no staining to strong staining are shown, using tissues of HNSCC patients who received radiation therapy. b, Kaplan-Meier curves for overall survival based on immunoreactivity score in HNSCC patients that received radiotherapy (n = 85). HNSCC patients were classified into the patients with low CBR1 (n = 70) and the patients with high CBR1 (n = 15). Scale bar of non-magnified; 200 μm, magnified; 50 μm

Back to article page